Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
IPOPEMA SecuritiesWAR:IPE -1.35%57 Altman Z-Score is 1.46 as of Jul. 14, 2026, which is 14% above its 10-year median of 1.28. GuruFocus rates WAR:IPE with a GF Score™ of 57/100 and a GF Value™ of zł3.62 (Significantly Overvalued). The stock has 8 warning signs investors should review. Among 661 Capital Markets companies, IPOPEMA Securities ranks worse than 64.9% on this metric.
The Altman Z-Score is a model designed to predict the likelihood of a company going bankrupt within the next two years. Created by American finance professor Edward Altman in 1968, the model is specifically designed for publicly traded manufacturing companies with assets greater than $1 million.
Warning Sign:
Altman Z-score of 1.47 is in distress zone. This implies bankruptcy possibility in the next two years.
IPOPEMA Securities has a Altman Z-Score of 1.46, indicating it is in Distress Zones. This implies bankrupcy possibility in the next two years.
The zones of discrimination were as such:
When Altman Z-Score <= 1.8, it is in Distress Zones.
When Altman Z-Score >= 3, it is in Safe Zones.
When Altman Z-Score is between 1.8 and 3, it is in Grey Zones.
The historical rank and industry rank for IPOPEMA Securities's Altman Z-Score or its related term are showing as below:
WAR:IPE'
s Altman Z-Score Range Over the Past 10 Years
Min: 0.46 Med: 1.28 Max: 1.89
Current: 1.47
During the past 13 years, IPOPEMA Securities's highest Altman Z-Score was 1.89. The lowest was 0.46. And the median was 1.28.
X1: The Working Capital/Total Assets (WC/TA) ratio is a measure of the net liquid assets of the firm relative to the total capitalization. Working capital is defined as the difference between current assets and current liabilities. Ordinarily, a firm experiencing consistent operating losses will have shrinking current assets in relation to total assets. Altman found this one proved to be the most valuable liquidity ratio comparing with the current ratio and the quick ratio. This is however the least significant of the five factors.
X2: Retained Earnings/Total Assets: the RE/TA ratio measures the leverage of a firm. Retained earnings is the account which reports the total amount of reinvested earnings and/or losses of a firm over its entire life. Those firms with high RE, relative to TA, have financed their assets through retention of profits and have not utilized as much debt.
X3, Earnings Before Interest and Taxes/Total Assets (EBIT/TA): This ratio is a measure of the true productivity of the firm's assets, independent of any tax or leverage factors. Since a firm's ultimate existence is based on the earning power of its assets, this ratio appears to be particularly appropriate for studies dealing with corporate failure. This ratio continually outperforms other profitability measures, including cash flow.
X4, Market Value of Equity/Book Value of Total Liabilities (MVE/TL): The measure shows how much the firm's assets can decline in value (measured by market value of equity plus debt) before the liabilities exceed the assets and the firm becomes insolvent.
X5, Revenue/Total Assets (S/TA): The capital-turnover ratio is a standard financial ratio illustrating the sales generating ability of the firm's assets.
Altman Z-Score does not apply to financial companies.
IPOPEMA Securities Altman Z-Score Related Terms
IPOPEMA Securities Altman Z-Score Historical Data
* Premium members only.
The historical data trend for IPOPEMA Securities's Altman Z-Score can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
WAR:IPE vs MS, GS, SCHW: Altman Z-Score Comparison
For the Capital Markets subindustry, IPOPEMA Securities's Altman Z-Score, along with its competitors' market caps and Altman Z-Score data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
IPOPEMA Securities Altman Z-Score vs Capital Markets Industry
For the Capital Markets industry and Financial Services sector, IPOPEMA Securities's Altman Z-Score distribution charts can be found below:
* The bar in red indicates where IPOPEMA Securities's Altman Z-Score falls into.
Altman Z-Score model is an accurate forecaster of failure up to two years prior to distress. It can be considered the assessment of the distress of industrial corporations.
IPOPEMA Securities's Altman Z-Score for today is calculated with this formula:
Z
=
1.2
*
X1
+
1.4
*
X2
+
3.3
*
X3
+
0.6
*
X4
+
1.0
*
X5
=
1.2
*
0.1809
+
1.4
*
0.1959
+
3.3
*
0.0652
+
0.6
*
0.4522
+
1.0
*
0.4847
=
1.46
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency. GuruFocus does not calculate Altman Z-Score when X4 or X5 value is 0.
IPOPEMA Securities (WAR:IPE) has a Altman Z-Score of 1.46 as of Jul. 14, 2026. The Altman Z-score measures a company's bankruptcy risk. View historical data on IPOPEMA Securities and its competitors. This is 14% above median its historical median of 1.28. Over the past decade, IPOPEMA Securities' Altman Z-Score has ranged from 0.46 to 1.89. According to the industry distribution chart, IPOPEMA Securities ranks #429 out of 661 companies in the Capital Markets industry, placing it in the top 64.9%.
Is IPOPEMA Securities' Altman Z-Score too high?
IPOPEMA Securities' current Altman Z-Score of 1.46 is 14% above median its 10-year median of 1.28. Over the past 10 years, this metric has ranged from a low of 0.46 to a high of 1.89. The Capital Markets industry median Altman Z-Score is 2.62. IPOPEMA Securities' value of 1.46 is 44.3% below this industry median. Based on the distribution chart, IPOPEMA Securities ranks #429 out of 661 companies in the Capital Markets industry, which is below the industry midpoint. Overall, IPOPEMA Securities has a GF Score™ of 57/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does IPOPEMA Securities' Altman Z-Score compare to MS and GS?
According to the Capital Markets industry distribution chart, IPOPEMA Securities ranks #429 out of 661 companies for Altman Z-Score. This places IPOPEMA Securities in the lower half of its industry. The industry median Altman Z-Score is 2.62. IPOPEMA Securities' value of 1.46 is 44.3% below this benchmark. Historically, IPOPEMA Securities' own Altman Z-Score has ranged from 0.46 to 1.89 over the past decade. While the company's 10-year median is 1.28 vs. the industry median of 2.62, IPOPEMA Securities has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Altman Z-Score for a Capital Markets company?
The median Altman Z-Score among Capital Markets companies is 2.62, based on 661 companies in the industry. Companies in the top quartile (top 25%) have a Altman Z-Score significantly above this median, while those in the bottom quartile fall well below. However, Altman Z-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. IPOPEMA Securities's current Altman Z-Score of 1.46 is 44.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Altman Z-Score mean?
A high Altman Z-Score can signal that a stock is expensive relative to its fundamentals. The Altman Z-score measures a company's bankruptcy risk. View historical data on IPOPEMA Securities and its competitors. For the Capital Markets industry, the median Altman Z-Score is 2.62 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. IPOPEMA Securities's current Altman Z-Score is 1.46, which is 14% above median its own 10-year median of 1.28. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is IPOPEMA Securities stock overvalued right now?
Based on GuruFocus' analysis, IPOPEMA Securities (WAR:IPE) is currently considered Significantly Overvalued. The stock's GF Value™ is zł3.62, compared to a current price of zł7.30 — trading 101.7% above its estimated fair value. The current Altman Z-Score is 1.46, which is 14% above median its 10-year median of 1.28 and 44.3% below the Capital Markets industry median of 2.62. IPOPEMA Securities' overall GF Score™ is 57/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Altman Z-Score calculated?
Altman Z-Score is calculated from a company's financial statements. For IPOPEMA Securities (WAR:IPE), the current Altman Z-Score is 1.46 as of Jul. 14, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is IPOPEMA Securities (WAR:IPE) Overvalued in 2026?
Based on GuruFocus' analysis, IPOPEMA Securities stock appears to be overvalued.
The current stock price of zł7.30 is trading 101.7% above its estimated GF Value™ of zł3.62.
GuruFocus considers IPOPEMA Securities to be Significantly Overvalued.
Key valuation signals for WAR:IPE:
Altman Z-Score: 1.46 (14% above median its 10-year median of 1.28)
GF Value™: zł3.62 vs. price of zł7.30 (101.7% above fair value)
Industry Position: 44.3% below the Capital Markets median (#429 of 661)
No single metric tells the full story. See the WAR:IPE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
IPOPEMA Securities SA is focused on brokerage activities, Business and management consulting, running an investment fund company and creating and managing investment funds, Management of portfolios of brokerage financial instruments, IT management activities, and IT consulting activities. It specializes in brokerage and company analysis services, investment banking services, as well as the distribution of investment products and investment advisory services addressed to a wide range of individual investors, the creation and management of closed-end and open-end investment funds and asset management, as well as business and IT consulting services.
57GF Score
Get the complete analysis for WAR:IPE
Altman Z-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
WAR:IPE has been successfully added to your 
